Sudemycin e influences alternative splicing and changes chromatin modifications

Nucleic Acids Research

Volumn 42, Issue 8, 2014, Pages 4947-4961

  Convertini, Paolo ^a   Shen, Manli ^a   Potter, Philip M ^b   Palacios, Gustavo ^b   Lagisetti, Chandraiah ^b,d   De La Grange, Pierre ^c   Horbinski, Craig ^a   Fondufe Mittendorf, Yvonne N ^a   Webb, Thomas R ^b,d   Stamm, Stefan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c SAINT LOUIS HOSPITAL   (France)

^d SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HISTONE H3; MESSENGER RNA; PROTEIN SF3B1; SMALL NUCLEAR RIBONUCLEOPROTEIN; SUDEMYCIN E; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CHROMATIN CONDENSATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; EXON; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN INTERACTION;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN; CYTOTOXINS; EPOXY COMPOUNDS; GENE EXPRESSION; HEK293 CELLS; HISTONES; HUMANS; NEOPLASMS; PHOSPHOPROTEINS; RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR; SPIRO COMPOUNDS;

EID: 84899838206     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku151     Document Type: Article

References (40)

1. Behzadnia, N., Golas, M.M., Hartmuth, K., Sander, B., Kastner, B., Deckert, J., Dube, P., Will, C.L., Urlaub, H., Stark, H. et al. (2007) Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes. EMBO J., 26, 1737-1748.
2. Gozani, O., Potashkin, J. and Reed, R. (1998) A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol. Cell. Biol., 18, 4752-4760.
3. Wahl, M.C., Will, C.L. and Luhrmann, R. (2009) The spliceosome: design principles of a dynamic RNP machine. Cell, 136, 701-718.
4. Lardelli, R.M., Thompson, J.X., Yates, J.R. III and Stevens, S.W. (2010) Release of SF3 from the intron branchpoint activates the first step of pre-mRNA splicing. RNA, 16, 516-528.
5. Schor, I.E., Allo, M. and Kornblihtt, A.R. (2010) Intragenic chromatin modifications: a new layer in alternative splicing regulation. Epigenetics, 5, 174-179.
6. Dujardin, G., Lafaille, C., Petrillo, E., Buggiano, V., Gomez Acuna, L.I., Fiszbein, A., Godoy Herz, M.A., Nieto Moreno, N., Munoz, M.J., Allo, M. et al. (2013) Transcriptional elongation and alternative splicing. Biochim. Biophys. Acta., 1829, 134-140.
7. Andersson, R., Enroth, S., Rada-Iglesias, A., Wadelius, C. and Komorowski, J. (2009) Nucleosomes are well positioned in exons and carry characteristic histone modifications. Genome Res., 19, 1732-1741.
8. Schwartz, S., Meshorer, E. and Ast, G. (2009) Chromatin organization marks exon-intron structure. Nat. Struct. Mol. Biol., 16, 990-995.
9. Sims, R.J. III, Millhouse, S., Chen, C.F., Lewis, B.A., Erdjument-Bromage, H., Tempst, P., Manley, J.L. and Reinberg, D. (2007) Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell, 28, 665-676.
10. Klinck, R., Bramard, A., Inkel, L., Dufresne-Martin, G., Gervais-Bird, J., Madden, R., Paquet, E.R., Koh, C., Venables, J.P., Prinos, P. et al. (2008) Multiple alternative splicing markers for ovarian cancer. Cancer Res., 68, 657-663.
11. Misquitta-Ali, C.M., Cheng, E., O'Hanlon, D., Liu, N., McGlade, C.J., Tsao, M.S. and Blencowe, B.J. (2011) Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol. Cell. Biol., 31, 138-150.
12. Venables, J.P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E. et al. (2009) Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol., 16, 670-676.
13. Hirschfeld, M., zur Hausen, A., Bettendorf, H., Jager, M. and Stickeler, E. (2009) Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer. Cancer Res., 69, 2082-2090.
14. Collesi, C., Santoro, M.M., Gaudino, G. and Comoglio, P.M. (1996) A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol., 16, 5518-5526.
15. Ghigna, C., Giordano, S., Shen, H., Benvenuto, F., Castiglioni, F., Comoglio, P.M., Green, M.R., Riva, S. and Biamonti, G. (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol. Cell, 20, 881-890.
16. Zink, D., Fischer, A.H. and Nickerson, J.A. (2004) Nuclear structure in cancer cells. Nat. Rev. Cancer, 4, 677-687.
17. Schor, I.E., Lleres, D., Risso, G.J., Pawellek, A., Ule, J., Lamond, A.I. and Kornblihtt, A.R. (2012) Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. PloS One, 7, e48084.
18. Nakajima, H., Hori, Y., Terano, H., Okuhara, M., Manda, T., Matsumoto, S. and Shimomura, K. (1996) New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J. Antibiot. (Tokyo), 49, 1204-1211.
19. Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H. et al. (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat. Chem. Biol., 3, 576-583.
20. Roybal, G.A. and Jurica, M.S. (2010) Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation. Nucleic Acids Res., 38, 6664-6672.
21. Corrionero, A., Minana, B. and Valcarcel, J. (2011) Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev., 25, 445-459.
22. Lagisetti, C., Pourpak, A., Goronga, T., Jiang, Q., Cui, X., Hyle, J., Lahti, J.M., Morris, S.W. and Webb, T.R. (2009) Synthetic mRNA splicing modulator compounds with in vivo antitumor activity. J. Med. Chem., 52, 6979-6990.
23. Fan, L., Lagisetti, C., Edwards, C.C., Webb, T.R. and Potter, P.M. (2011) Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing. ACS Chem.l Biol., 6, 582-589.
24. Petak, I., Douglas, L., Tillman, D.M., Vernes, R. and Houghton, J.A. (2000) Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. Clin. Cancer Res., 6, 4119-4127.
25. Kapur, K., Jiang, H., Xing, Y. and Wong, W.H. (2008) Cross-hybridization modeling on Affymetrix exon arrays. Bioinformatics, 24, 2887-2893.
26. de La Grange, P. (2012) In: Stamm, S., Smith, C. and Luhrmann, L. (eds), Alternative pre-mRNA Splicing: Theory and Protocols. Weinheim, Wiley-Blackwell, pp. 261-267.
27. Shen, S., Warzecha, C.C., Carstens, R.P. and Xing, Y. (2010) MADS+: discovery of differential splicing events from Affymetrix exon junction array data. Bioinformatics, 26, 268-269.
28. Bessonov, S., Anokhina, M., Will, C.L., Urlaub, H. and Luhrmann, R. (2008) Isolation of an active step I spliceosome and composition of its RNP core. Nature, 452, 846-850.
29. Behrens, S.E., Tyc, K., Kastner, B., Reichelt, J. and Luhrmann, R. (1993) Small nuclear ribonucleoprotein (RNP) U2 contains numerous additional proteins and has a bipartite RNP structure under splicing conditions. Mol. Cell. Biol., 13, 307-319.
30. Montes, M., Becerra, S., Sanchez-Alvarez, M. and Sune, C. (2012) Functional coupling of transcription and splicing. Gene, 501, 104-117.
31. de Almeida, S.F., Grosso, A.R., Koch, F., Fenouil, R., Carvalho, S., Andrade, J., Levezinho, H., Gut, M., Eick, D., Gut, I. et al. (2011) Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nat. Struct. Mol. Biol., 18, 977-983.
32. Schwartz, Y.B. and Pirrotta, V. (2007) Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet., 8, 9-22.
33. Girard, C., Will, C.L., Peng, J., Makarov, E.M., Kastner, B., Lemm, I., Urlaub, H., Hartmuth, K. and Luhrmann, R. (2012) Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion. Nat. Commun., 3, 994.
34. Tilgner, H., Nikolaou, C., Althammer, S., Sammeth, M., Beato, M., Valcarcel, J. and Guigo, R. (2009) Nucleosome positioning as a determinant of exon recognition. Nat. Struct. Mol. Biol., 16, 996-1001.
35. Luco, R.F., Pan, Q., Tominaga, K., Blencowe, B.J., Pereira-Smith, O.M. and Misteli, T. (2010) Regulation of alternative splicing by histone modifications. Science, 327, 996-1000.
36. Zhou, H.L., Luo, G., Wise, J.A. and Lou, H. (2013) Regulation of alternative splicing by local histone modifications: potential roles for RNA-guided mechanisms. Nucleic Acids Res., 42, 701-713.
37. Kolasinska-Zwierz, P., Down, T., Latorre, I., Liu, T., Liu, X.S. and Ahringer, J. (2009) Differential chromatin marking of introns and expressed exons by H3K36me3. Nat. Genet., 41, 376-381.
38. Halley-Stott, R.P. and Gurdon, J.B. (2013) Epigenetic memory in the context of nuclear reprogramming and cancer. Brief Funct. Genomics, 12, 164-173.
39. Suva, M.L., Riggi, N. and Bernstein, B.E. (2013) Epigenetic reprogramming in cancer. Science, 339, 1567-1570.
40. Boon, K.L., Grainger, R.J., Ehsani, P., Barrass, J.D., Auchynnikava, T., Inglehearn, C.F. and Beggs, J.D. (2007) prp8 mutations that cause human retinitis pigmentosa lead to a U5 snRNP maturation defect in yeast. Nat. Struct. Mol. Biol., 14, 1077-1083.